By Ryan Grim, Glenn Greenwald
January 07, 2019 "Information Clearing House" - When each new Congress is gaveled into session, the chambers attach symbolic importance to the first piece of legislation to be considered. For that reason, it bears the lofty designation of H.R.1 in the House, and S.1 in the Senate.
In the newly controlled Democratic House, H.R.1 – meant to signal the new majority’s priorities – is an anti-corruption bill that combines election and campaign finance reform, strengthening of voting rights, and matching public funds for small-dollar candidates. In the new 2017 Senate, the GOP-controlled S.1 was a bill, called the “Tax Cuts and Jobs Act,” that, among other provisions, cut various forms of corporate taxes.
But in the 2019 GOP-controlled Senate, the first bill to be considered – S.1 – is not designed to protect American workers, bolster U.S. companies, or address the various debates over border security and immigration. It’s not a bill to open the government. Instead, according to multiple sources involved in the legislative process, S.1 will be a compendium containing a handful of foreign-policy related measures, a main one of which is a provision, with Florida’s GOP Sen. Marco Rubio as a lead sponsor, to defend the Israeli government. The bill is a top legislative priority for AIPAC.
In the previous Congress, that measure was known as S.170, and it gives state and local governments explicit legal authority to boycott any U.S. companies which themselves are participating in a boycott against Israel. As the Intercept reported last month, 26 states now have enacted some version of a law to punish or otherwise sanction entities which participate in or support the boycott of Israel, while similar laws are pending in at least 13 additional states. Rubio’s bill is designed to strengthen the legal basis to defend those Israel-protecting laws from constitutional challenge.
Are You Tired Of The Lies And Non-Stop Propaganda?
Due to attack by trolls it is necessary to register to comment on articles. We ask that you post comments if you have information that confirms or challenges the information or opinion offered in the article. Please provide links to information that supports your views. It is not acceptable to make personal attacks on either the author or other members of the ICH community, doing so will result in cancellation of your posting privileges'.